AG-348

mitapivat · Agios Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AG-348, covering 2014-10-22 to 2022-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Finding Study of AG-348 in Sickle Cell Disease [EARLY_Phase 1]